US private equity firm Vivaris Capital has partnered with technology enabled investment bank and broker-dealer, Entoro Capital as part of its ongoing efforts to raise capital for its first structured financial product for United Cancer Centres (UCC), known as the Vican.
The Vican combines a private equity investment with investment-grade securities, and allows clients to invest in scenarios with high growth and return potential while only taking the risk of the investment-grade portfolio. UCC is the first institutional healthcare system in the US to offer integrative cancer care under recently enacted ‘right to try’ legislation. This would give patients the ability to opt for therapies that have cleared a phase I clinical trial for safety but have
Continue reading with a subscription to the SRP market intelligence platform.
Request DemoAlready a subscriber? Login